USPTO serial 79270408
AIDIAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 3, 2020
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AIDIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karin Segall
Karin Segall LEASON ELLIS LLPOne North Lexington Avenue, Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for use in laboratories and for research use; chemical products, namely, diagnostic reagents for scientific use; diagnostic preparations, other than for medical use; diagnostic testing materials, namely, diagnostic test kits comprised of chemical probes and buffers for use in laboratory tests and hygiene tests, other than for medical use; diagnostic reagents for laboratory use; DNA primers for laboratory use; chemicals used to extract nucleic acid from biological specimens, other than for medical use; reagents in the nature of polymerase and buffers for use in the biotechnology field; chemicals for use as DNA extraction controls, other than for medical use; chemicals for use as RNA extraction controls, other than for medical use; negative controls, namely, negative control solutions for use in laboratory tests; calibrating solutions, namely, calibrating fluids for blood analyzers | ACTIVE | — |
| 005 | Chemical preparations for medical use, namely, for detecting infectious diseases, disorders, proteins, diabetes management, hormones, hygiene, viruses, bacteria, organs and blood; diagnostic preparations for medical use; diagnostic testing materials for medical use, namely, medical diagnostic reagents and assays for testing body fluids; diagnostic substances for medical purposes; pharmaceutical preparations for the treatment of bacterial infections; medical diagnostic reagents; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, faeces analysis; diagnostic reagents for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic kits comprising diagnostic reagents, monoclonal antibodies and buffers for medical use; reagents for medical purposes; chemical reagents for medical purposes; cartridges containing reagents for use in calibrating portable blood analyzers | ACTIVE | — |
| 010 | Diagnostic apparatus for medical and veterinary purposes for testing infectious diseases, disorders, diabetes management, proteins, hormones, hygiene, viruses, bacteria, organs and blood; medical apparatus and instruments for diagnostic use, namely, apparatus and instruments for medical diagnostic testing in the fields of point-of-care, near-patient-testing, infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders, tissue-based diagnostic testing, cytology and cell-based testing; electronic apparatus for medical diagnosis, namely, electromagnetic medical diagnostic imaging apparatus; medical apparatus and instruments for testing bodily fluids; blood, tissue, mucosa and faeces testing apparatus, namely, blood and mucosa, tissue, faeces sampling tubes; medical devices for use in treating or diagnosing infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; laboratory equipment for use in the field of medical diagnostics; medical DNA sequencers for medical diagnostic purposes; medical diagnostic device, namely, a system comprising a hand-held meter, lancets, test strips and control solution for infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders; replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
| 037 | Installation, repair and maintenance of medical apparatus and instruments; installation, repair and maintenance of medical diagnostic apparatus and instruments; providing information and consultation relating to the installation, repair and maintenance of medical apparatus and instruments; providing information and consultation relating to the installation, repair and maintenance of medical diagnostic apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aidian Oy
- Other trademarks owned by Aidian Oy
- Other trademarks owned by Aidian Oy
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 037
- Similar marks named AIDIAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 3, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 7, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 12, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 12, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 3, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 22, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 22, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 22, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 22, 2020 | DMCC | DATA MODIFICATION COMPLETED | — |
| May 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 6, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 21, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 21, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 1, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |